Literature DB >> 16803440

Ultrasonography in diagnosing colorectal cancers in patients presenting with abdominal distension.

Shyr-Chyr Chen1, Zui-Shen Yen, Hsiu-Po Wang, Chien-Chang Lee, Chiung-Yuan Hsu, Wen-Jone Chen, Chien-Yao Hsu, Hong-Shiee Lai, Fang-Yue Lin, Wei-Jao Chen.   

Abstract

OBJECTIVE: To determine the usefulness of abdominal ultrasonography for diagnosing colorectal cancer in patients presenting with abdominal distension. DESIGN, SETTING AND PARTICIPANTS: A prospective case series of consecutive adult patients with abdominal distension admitted to the National Taiwan University Hospital between January 2001 and July 2004. All participants were examined by abdominal ultrasonography. Those with suspected colorectal tumours on ultrasonography had follow-up colonoscopy, while all other patients had computed tomography scans. MAIN OUTCOME MEASURES: Accuracy of abdominal ultrasonography for diagnosing colorectal cancer in patients with abdominal distension; incidence of colorectal cancer.
RESULTS: Of 511 patients eligible for inclusion in our study, 97 (19.0%) were confirmed to have colorectal cancer. For diagnosis of colorectal cancer, ultrasonography had a sensitivity of 92.8% (95% CI, 85.2%-96.8%); a specificity of 98.8% (95% CI, 97.0%-99.6%); a positive predictive value of 94.7% (95% CI, 87.6%-98.0%); a negative predictive value of 98.3% (95% CI 96.4%-99.3%); and an accuracy of 97.7%.
CONCLUSION: Ultrasonography is a sensitive tool for diagnosing colorectal cancer in patients presenting with abdominal distension.

Entities:  

Mesh:

Year:  2006        PMID: 16803440     DOI: 10.5694/j.1326-5377.2006.tb00415.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  1 in total

1.  Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4.

Authors:  Guangru Xu; Hongxing Zhu; Jinhua Xu; Yan Wang; Yang Zhang; Minghui Zhang; Dichao Zhu
Journal:  J Cell Mol Med       Date:  2020-02-26       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.